Articles

Poll

Podcasts

Slideshows

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

A propensity score-matched study from ASH 2024 suggests GLP-1 RA use reduced VTE risk in type 2 diabetes.

GLP-1 Receptor Agonists Could Reduce Stroke Risk in Type 2 Diabetes

The August 2024 cardiology month in review highlights critical data from the European Society of Cardiology Congress 24 and the latest updates on finerenone.

Cardiology Month in Review: August 2024

Thrombotic risk is more likely influenced by disease status than hormonal contraception exposure in women with SCD.

Disease Status Influences VTE Risk in Women with Sickle Cell Disease

A recent analysis found risk factors linked to an embolism after VTE included Black race, interstitial fibrosis, advanced-stage disease, and increased operative duration.

Study Identifies Critical Risk Factors for VTE After Pulmonary Resection 

Presented at ASH 2023, findings of a new study showed patients with sickle cell disease and venous thromboembolism have longitudinal worsening of left ventricular diastolic and right-sided cardiac function.

Sickle Cell Disease with Venous Thromboembolism Linked to Higher Mortality

Anthos Therapeutics halts their phase 2 AZALEA-TIMI 71 trial due to significant reduction in bleeding events with abelacimab, making it a potential breakthrough in anticoagulation therapy for atrial fibrillation.

Abelacimab Demonstrates "Overwhelming" Efficacy vs Rivaroxaban in Phase 2b Trial

Results of the PREVENT CLOT study indicate use of aspirin was as effective as low-molecular-weight heparin for reducing incidence of mortality in patients hospitalized with a traumatic fracture. 

Aspirin Deemed as Effective as Heparin in Patients Hospitalized with Traumatic Fractures

A reduction in aspirin use was associated with significantly less bleeding and health care use, without an increase in thrombotic outcomes.



Reducing Aspirin Use Improves Outcomes in Patients with AF, VTE Receiving Warfarin

A recent study indicated no evident VTE risk in patients with eczema, despite FDA black box warnings for the drug class.

No Clear Risk for VTE in Eczema Patients Receiving JAK Inhibitors

New findings suggest low-dose rivaroxaban plus aspirin was associated
with lower VTE risk compared with aspirin alone. 

Continuous VTE Risk Observed After Lower Extremity Revascularization in Patients with PAD

The HCPLive venous thromboembolism page is a resource for medical news and expert insights on VTE. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for thrombotic disease, and more.